[(2R,5R)-5-[3-[(4-anilino-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclohexyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclopentyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-phenoxy-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(3-phenylphenyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-piperidin-1-yl-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

C125H149N19O55P6 — CID 160740416

About [(2R,5R)-5-[3-[(4-anilino-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclohexyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclopentyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-phenoxy-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(3-phenylphenyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-piperidin-1-yl-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

[(2R,5R)-5-[3-[(4-anilino-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclohexyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclopentyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-phenoxy-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(3-phenylphenyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-piperidin-1-yl-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate (PubChem CID 160740416) has the molecular formula C125H149N19O55P6 and a molecular weight of 2983.49 g/mol. Its IUPAC name is [(2R,5R)-5-[3-[(4-anilino-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclohexyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclopentyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-phenoxy-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(3-phenylphenyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-piperidin-1-yl-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate.

Molecular Properties

• Compound Name: [(2R,5R)-5-[3-[(4-anilino-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclohexyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclopentyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-phenoxy-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(3-phenylphenyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-piperidin-1-yl-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
• PubChem CID: 160740416
• Molecular Formula: C125H149N19O55P6
• Molecular Weight: 2983.49 g/mol
• Exact Mass: 2981.79
• IUPAC Name: [(2R,5R)-5-[3-[(4-anilino-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclohexyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclopentyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-phenoxy-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(3-phenylphenyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-piperidin-1-yl-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
• SMILES: O=c1ccn([C@@H]2O[C@H](COP(=O)(O)O)C(O)C2O)c(=O)n1Cc1cc(C2CCCC2)ccn1.O=c1ccn([C@@H]2O[C@H](COP(=O)(O)O)C(O)C2O)c(=O)n1Cc1cc(C2CCCCC2)ccn1.O=c1ccn([C@@H]2O[C@H](COP(=O)(O)O)C(O)C2O)c(=O)n1Cc1cc(N2CCCCC2)ccn1.O=c1ccn([C@@H]2O[C@H](COP(=O)(O)O)C(O)C2O)c(=O)n1Cc1cc(Nc2ccccc2)ccn1.O=c1ccn([C@@H]2O[C@H](COP(=O)(O)O)C(O)C2O)c(=O)n1Cc1cc(Oc2ccccc2)ccn1.O=c1ccn([C@@H]2O[C@H](COP(=O)(O)O)C(O)C2O)c(=O)n1Cc1cccc(-c2ccccc2)c1
• InChI: InChI=1S/C22H23N2O9P.C21H23N4O9P.C21H22N3O10P.C21H28N3O9P.C20H27N4O9P.C20H26N3O9P/c25-18-9-10-23(21-20(27)19(26)17(33-21)13-32-34(29,30)31)22(28)24(18)12-14-5-4-8-16(11-14)15-6-2-1-3-7-15;26-17-7-9-24(20-19(28)18(27)16(34-20)12-33-35(30,31)32)21(29)25(17)11-15-10-14(6-8-22-15)23-13-4-2-1-3-5-13;25-17-7-9-23(20-19(27)18(26)16(34-20)12-32-35(29,30)31)21(28)24(17)11-13-10-15(6-8-22-13)33-14-4-2-1-3-5-14;25-17-7-9-23(20-19(27)18(26)16(33-20)12-32-34(29,30)31)21(28)24(17)11-15-10-14(6-8-22-15)13-4-2-1-3-5-13;25-16-5-9-23(19-18(27)17(26)15(33-19)12-32-34(29,30)31)20(28)24(16)11-13-10-14(4-6-21-13)22-7-2-1-3-8-22;24-16-6-8-22(19-18(26)17(25)15(32-19)11-31-33(28,29)30)20(27)23(16)10-14-9-13(5-7-21-14)12-3-1-2-4-12/h1-11,17,19-21,26-27H,12-13H2,(H2,29,30,31);1-10,16,18-20,27-28H,11-12H2,(H,22,23)(H2,30,31,32);1-10,16,18-20,26-27H,11-12H2,(H2,29,30,31);6-10,13,16,18-20,26-27H,1-5,11-12H2,(H2,29,30,31);4-6,9-10,15,17-19,26-27H,1-3,7-8,11-12H2,(H2,29,30,31);5-9,12,15,17-19,25-26H,1-4,10-11H2,(H2,28,29,30)/t17-,19?,20?,21-;3*16-,18?,19?,20-;2*15-,17?,18?,19-/m111111/s1
• InChIKey: RVMRQNNZWPIRNT-MRVJWPLASA-N
• XLogP: -0.41
• TPSA: 1051.65 Ų
• H-Bond Donors: 25
• H-Bond Acceptors: 62
• Rotatable Bonds: 44
• Heavy Atoms: 205
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2983.49
LogP ≤ 5	-0.41
H-Bond Donors ≤ 5	25
H-Bond Acceptors ≤ 10	62

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'phosphor', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of [(2R,5R)-5-[3-[(4-anilino-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclohexyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclopentyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-phenoxy-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(3-phenylphenyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-piperidin-1-yl-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate?

The IUPAC name of [(2R,5R)-5-[3-[(4-anilino-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclohexyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclopentyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-phenoxy-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(3-phenylphenyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-piperidin-1-yl-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate (CID 160740416) is [(2R,5R)-5-[3-[(4-anilino-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclohexyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclopentyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-phenoxy-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(3-phenylphenyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-piperidin-1-yl-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate.

What is the SMILES notation for [(2R,5R)-5-[3-[(4-anilino-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclohexyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclopentyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-phenoxy-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(3-phenylphenyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-piperidin-1-yl-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate?

The canonical SMILES for [(2R,5R)-5-[3-[(4-anilino-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclohexyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclopentyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-phenoxy-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(3-phenylphenyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-piperidin-1-yl-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate is O=c1ccn([C@@H]2O[C@H](COP(=O)(O)O)C(O)C2O)c(=O)n1Cc1cc(C2CCCC2)ccn1.O=c1ccn([C@@H]2O[C@H](COP(=O)(O)O)C(O)C2O)c(=O)n1Cc1cc(C2CCCCC2)ccn1.O=c1ccn([C@@H]2O[C@H](COP(=O)(O)O)C(O)C2O)c(=O)n1Cc1cc(N2CCCCC2)ccn1.O=c1ccn([C@@H]2O[C@H](COP(=O)(O)O)C(O)C2O)c(=O)n1Cc1cc(Nc2ccccc2)ccn1.O=c1ccn([C@@H]2O[C@H](COP(=O)(O)O)C(O)C2O)c(=O)n1Cc1cc(Oc2ccccc2)ccn1.O=c1ccn([C@@H]2O[C@H](COP(=O)(O)O)C(O)C2O)c(=O)n1Cc1cccc(-c2ccccc2)c1.

What is the InChIKey of [(2R,5R)-5-[3-[(4-anilino-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclohexyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclopentyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-phenoxy-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(3-phenylphenyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-piperidin-1-yl-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate?

The InChIKey is RVMRQNNZWPIRNT-MRVJWPLASA-N. The full InChI is InChI=1S/C22H23N2O9P.C21H23N4O9P.C21H22N3O10P.C21H28N3O9P.C20H27N4O9P.C20H26N3O9P/c25-18-9-10-23(21-20(27)19(26)17(33-21)13-32-34(29,30)31)22(28)24(18)12-14-5-4-8-16(11-14)15-6-2-1-3-7-15;26-17-7-9-24(20-19(28)18(27)16(34-20)12-33-35(30,31)32)21(29)25(17)11-15-10-14(6-8-22-15)23-13-4-2-1-3-5-13;25-17-7-9-23(20-19(27)18(26)16(34-20)12-32-35(29,30)31)21(28)24(17)11-13-10-15(6-8-22-13)33-14-4-2-1-3-5-14;25-17-7-9-23(20-19(27)18(26)16(33-20)12-32-34(29,30)31)21(28)24(17)11-15-10-14(6-8-22-15)13-4-2-1-3-5-13;25-16-5-9-23(19-18(27)17(26)15(33-19)12-32-34(29,30)31)20(28)24(16)11-13-10-14(4-6-21-13)22-7-2-1-3-8-22;24-16-6-8-22(19-18(26)17(25)15(32-19)11-31-33(28,29)30)20(27)23(16)10-14-9-13(5-7-21-14)12-3-1-2-4-12/h1-11,17,19-21,26-27H,12-13H2,(H2,29,30,31);1-10,16,18-20,27-28H,11-12H2,(H,22,23)(H2,30,31,32);1-10,16,18-20,26-27H,11-12H2,(H2,29,30,31);6-10,13,16,18-20,26-27H,1-5,11-12H2,(H2,29,30,31);4-6,9-10,15,17-19,26-27H,1-3,7-8,11-12H2,(H2,29,30,31);5-9,12,15,17-19,25-26H,1-4,10-11H2,(H2,28,29,30)/t17-,19?,20?,21-;3*16-,18?,19?,20-;2*15-,17?,18?,19-/m111111/s1.

What are the key properties of [(2R,5R)-5-[3-[(4-anilino-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclohexyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclopentyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-phenoxy-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(3-phenylphenyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-piperidin-1-yl-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate?

[(2R,5R)-5-[3-[(4-anilino-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclohexyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclopentyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-phenoxy-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(3-phenylphenyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-piperidin-1-yl-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate has a molecular weight of 2983.49 g/mol, XLogP of -0.41, 44 rotatable bonds, 25 hydrogen bond donors, and 62 hydrogen bond acceptors.

Where does this data come from?

All data for [(2R,5R)-5-[3-[(4-anilino-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclohexyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[3-[(4-cyclopentyl-2-pyridinyl)methyl]-2,4-dioxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-phenoxy-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(3-phenylphenyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,5R)-5-[2,4-dioxo-3-[(4-piperidin-1-yl-2-pyridinyl)methyl]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate is sourced from PubChem (CID 160740416), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).